Craig Hopkinson
Hoofd Techniek/Wetenschap/O&O bij ALKERMES PLC
Vermogen: 3 M $ op 30-04-2024
Actieve functies van Craig Hopkinson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ALKERMES PLC | Hoofd Techniek/Wetenschap/O&O | 30-05-2017 | - |
Loopbaan van Craig Hopkinson
Eerdere bekende functies van Craig Hopkinson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ALBIREO PHARMA, INC. | Directeur/Bestuurslid | 01-12-2022 | 02-03-2023 |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Hoofd Techniek/Wetenschap/O&O | 01-05-2017 | 01-01-2020 |
VERTEX PHARMACEUTICALS INCORPORATED | Hoofd Techniek/Wetenschap/O&O | 01-07-2014 | 01-05-2017 |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Corporate Officer/Principal | 01-01-2013 | 01-07-2014 |
President | 01-10-2011 | 01-12-2012 |
Opleiding van Craig Hopkinson
University of the Free State | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Ierland | 2 |
Zuid-Afrika | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ALKERMES PLC | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
- Beurs
- Insiders
- Craig Hopkinson
- Ervaring